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Abstract 
Receptor component protein (RCP) is a 148 amino acid intracellular peripheral 
membrane protein, previously identified as promoting the coupling of CGRP to cAMP 
production at the CGRP receptor, a heterodimer of calcitonin receptor like-receptor 
(CLR), a family B G protein-coupled receptor (GPCR) and receptor activity modifying 
protein 1 (RAMP1). We extend these observations to show that it selectively 
enhances CGRP receptor coupling to Gs but not Gq or pERK activation. At other 
family B GPCRs, it enhances cAMP production at the calcitonin, corticotrophin 
releasing factor type 1a and  glucagon-like peptide type 2 receptors with their 
cognate ligands but not at the adrenomedullin type 1 (AM1), gastric inhibitory 
peptide and glucagon-like peptide type 1 receptors, all expressed in transfected 
HEK293S cells. However, there is also cell-line variability as RCP did not enhance 
cAMP production at the endogenous calcitonin receptor in HEK293T cells and it has 
previously been reported that it is active on the AM1 receptor expressed on NIH3T3 
cells. RCP appears to behave as a positive allosteric modulator at coupling a number 
of family B GPCRs to Gs, albeit in a manner that is regulated by cell-specific factors. It 
may exert its effects at the interface between the 2nd intracellular loop of the GPCR 
and Gs, although there is likely to be some overlap between this location and that 
occupied by the C-terminus of RAMPs if they bind to the GPCRs. 
 
Abbreviations 
AM Adrenomedullin, CGRP calcitonin gene-related peptide, CRF corticotrophin 
releasing factor, CT calcitonin, GIP gastric inhibitory polypeptide, GLP, glucagon-like 
polypeptide, GPCR G protein coupled receptor, HUVECs Human umbilical vein 
Journal Pre-proof
Jo
urn
al 
Pr
e-p
roo
f
3 
 
endothelial cells, ICL intracellular loop, RCP receptor component protein, TM 
transmembrane helix 
 
Keywords  
Adrenomedullin, accessory protein, GPCR signalling, CGRP, G protein coupling, 
allosteric modulator 
 
1. Introduction 
RCP is a 148 amino acid, 17 kDa peripheral membrane protein and its expression has 
been demonstrated in numerous cell lines [1]. It is found in vivo in the brain, spinal 
cord, the uterus as well as in vasculature. It is a component of human RNA 
polymerase III where it is known as rpc9; homologues of this protein are found in 
yeast [2]. In addition to its role in RNA synthesis, RCP is also important in G protein-
coupled receptor (GPCR) signalling. It is required for efficient coupling of the CGRP 
receptor to production of cAMP via Gs, the stimulatory G protein, as shown by 
knockdown of RCP expression [1, 3-5]. CGRP receptors consist of a family B GPCR, 
the calcitonin receptor-like receptor (CLR). This requires an accessory protein, 
receptor activity modifying protein 1 (RAMP1) for ligand binding and receptor 
expression [6, 7]. RCP is a third component of the receptor. It appears to physically 
associate with the receptor, interacting with its second intracellular loop (ICL2) [8]. In 
NIH3T3 cells, following challenge with CGRP, RCP translocates from the cell surface 
to the nucleus, perhaps suggesting a role in nuclear signalling in addition to 
facilitating Gs coupling [9]. Loss of RCP does not affect the affinity of CGRP for its 
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receptor, or significantly alter trafficking to the cell surface, and so is not required in 
order for CLR and RAMP1 to interact [3]. Decreases in RCP expression have been 
correlated with reduced sensitivity to CGRP under a number of physiological and 
pathological conditions [1].  
 
No effect is seen on the β2 adrenoreceptor or the adenosine 2A receptor following 
RCP knockdown, although the response of a peptide closely related to CGRP, 
adrenomedullin (AM), is also impaired by RCP knockdown in cells expressing its 
receptor (CLR in complex with RAMP2, a homologue of RAMP1) [3]. It remains an 
open question as to how far it can interact with other family B GPCRs.  
 
There is growing awareness that receptors can be influenced allosterically by 
compounds or proteins that bind to locations distinct from the normal agonist 
binding site [10]. By enhancing or reducing the interaction of an intracellular 
allosteric modulator of a GPCR there is the potential to ‘tune’ the physiological 
response. Moreover, many GPCRs activate a wide array of downstream signalling 
pathways, depending on the activating agonist; this is biased agonism. Thus, 
allosteric modulators have the potential to influence GPCR signalling bias. This is 
seen with RAMPs, as they modulate ligand binding and signalling to a range of family 
B GPCRs [11].  It is possible that RCP is also an allosteric modulator at some family B 
GPCRs. 
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We are still far from understanding the pharmacological importance of RCP. 
Furthermore, no work has been done to systematically explore whether RCP 
interacts with other family B GPCRs. In this study, we investigate whether RCP is an 
allosteric modulator of CGRP receptor signalling, and determine whether its actions 
apply to other family B receptors; adrenomedullin 1, calcitonin (CT), glucagon-like 
polypeptide (GLP)-1, GLP2, gastric inhibitory polypeptide (GIP)-1 and corticotrophin 
releasing factor (CRF) type 1. 
 
 
2. Materials and Methods 
2.1 Constructs 
HA-tagged CLR, CTR, CRF1a, GLP-1R and FLAG-tagged RAMPs were as described 
previously [12, 13]. The GIPR and GLP2R constructs were gifts from Dr. Simon Dowell 
(GSK, Stevenage, UK). All constructs were of human receptors.  
 
2.2 Peptides 
Human GLP-1 (7-36)NH2, GIP 1-42, and GLP2 (1-33)NH2 were synthesised by Alta 
Biosciences (University of Birmingham, Birmingham, UK). Human CGRP, AM, CRF 
and CT were purchased from Bachem (Bubendorf, Switzerland). All peptides were 
made as 1 mM stocks in water containing 0.1% BSA.  
 
2.3 Cell culture and transfections 
HEK293S, HEK293T and SK-N-MC cells were cultured in Dulbecco’s modified Eagles’s 
medium supplemented with 10% fetal calf serum and 5 % (v/v) 
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penicillin/streptomycin (Invitrogen) in a humidified 95% air/5% CO2 atmosphere. 
Human umbilical vein endothelial cells (HUVECs) – pooled donor (PromoCell) were 
cultured in Endothelial Cell Growth Media (PromoCell) medium supplemented with 5 
% streptomycin (Invitrogen) in a humidified 95% air/5% CO2 atmosphere. Cells were 
plated onto 6 well, 24 well or 96 well plates for transfection. 30 nM siRNA 
(Invitrogen) was transfected per well with Lipofectamine 3000 reagent 
(ThermoFisher) according to the manufacturer’s instructions to knock down 
endogenous RCP expression. 21-mer siRNA sequences to RCP were synthesised by 
Invitrogen: sense 5′-UCUGAAAGAGCAGCGUAAATT-3′  antisense 5′-
UUUACGCUGCUCUUUCAG-3′  . Control primers were scrambled sequences: 
UCUAGAAGACGUGCAGAAATT sense and UUU CUGCACGUCUUCUAGATT antisense.  
 
DNA transfections were performed 48 h later, with 2 μg per well in a 6 well plate, 0.5 
μg per well in a 24 well plate and 100 μg per well in a 96 well plate using 
Lipofectamine 3000 with P3000 reagent.  
 
2.4 Cell surface expressi n determined by ELISA 
ELISAs were performed in 24 well plates as previously [14] to determine cell surface 
expression of CLR and RAMPs in cells pretreated for 48h with either scrambled siRNA 
or RCP siRNA before transfection with CLR and RAMP1. 
 
2.5 Cell signalling assays 
The cell signalling assays were performed as previously described [15]. Briefly, 
transiently transfected cells were harvested and washed with PBS. They were then 
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resuspended in stimulation buffer (PBS containing 0.1% BSA and 0.5 mM isobutyl 
methylxanthine) and seeded at 3000 cells per well in 96-well white Optiplates. 
Ligands were added in the range of 1 pM to 1mM and cAMP accumulation was 
measured after 8 min stimulation using LANCE® cAMP Detection Kit (PerkinElmer). 
Concentrations of cAMP were calculated using a cAMP standard curve performed in 
parallel. pERK was determined using 30,000 cells per well according to the 
manufacturer’s instructions (CISBIO Phospho-ERK (Thr202/Tyr204) kits) and 
normalized to phorbol 12-myristate 13-acetate. Intracellular calcium experiments 
were performed by seeding cells into 96 well plates and growing in Dulbecco’s 
modified Eagles’s medium supplemented with 10% fetal calf serum and 5 % (v/v) 
penicillin/streptomycin. 48 h post transfection, media was replaced with Hanks 
buffered-saline without calcium. Intracellular calcium was then measured using a 
Fluo-4 Direct Calcium Assay kit (Thermo Fisher Scientific) upon stimulation with 
ligand, and values were normalized to ionomycin. All assays were read using a 
Mithras LB 940 plate reader (Berthold Technologies).  
 
2.6 RT-PCR details 
Media was removed from cells in a 6 well plate and cells were washed twice (PBS). 
Approximately 2x105 cells were used per extraction. RNA extraction was performed 
using RNAqueous-4PCR kit (Ambion). Complementary DNA was synthesised using a 
QuantiTect reverse transcription kit (Qiagen) and used in real-time PCR with primers 
(Table 1) synthesised and supplied by Sigma Aldrich. Electrophoresis was performed 
on a 2% agarose gel. The image was captured using G Box iChemi gel documentation 
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system and densitometry analysis performed using GeneTools (Syngene). mRNA 
levels of the genes of interest were normalised to GAPDH expression. 
 
Table 1 Primers used for PCR 
Oligonucleotides 
 
Sequence Amplicon 
size (bp) 
Human    
GAPDH  5’ - TGCACCACCAACTGCTTAGC- 3’ 87 
 5’ - GGCATGGACTGTGGTCATGAG- 3’ 
CLR 5’ - ACCAGGCCTTAGTAGCCACA - 3’ 298 
 5’ - ACAAATTGGGCCATGGATAA - 3’  
RAMP1 5’ - CTGCCAGGAGGCTAACTACG - 3’ 298 
 5’ - GACCACGATGAAGGGGTAGA - 3’  
RAMP2 5’ - GGGGGACGGTGAAGAACTAT - 3’ 227 
 5’ - GTTGGCAAAGTGGATCTGGT - 3’  
RAMP3 5’ - AACTTCTCCCGTTGCTGCT - 3’ 353 
 5’ - GACGGGTATAACGATCAGCG - 3’  
RCP 5’ - AGAGCAGCGTAAAGAAAGTGG - 3’ 
5’ - CTGACAATTTCAGGACTCTGGTG - 3’ 
129 
 
 
2.7 Data analysis 
Concentration-response curves were analysed via PRISM 7.0e (San Diego, CA). Data 
were fitted to obtain concentration-response curves using the three-parameter 
logistic equation for pEC50 and Emax values. Data was normalised according to the 
fitted basal and maximal responses for the RCP scrambled antisense control curves. 
Statistical analysis was performed using a Student’s t-test or one-way ANOVA with 
Bonferroni’s or Dunnett’s multiple comparisons as appropriate.  
 
2.8 Molecular modelling 
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 A molecular model of the RCP/CLR/RAMP1/Gαsβγ complex was built using the cryo-
EM structure of CLR/RAMP1/Gαsβγ (PDB ID: 6E3Y), and a homology model of RCP 
built in Modeller using the yeast homologue C17 as template (PDB ID: 3AYH). ICL2 
was previously identified as the RCP contact site [8]; we therefore placed the RCP 
model at a distance of 5 Å from the centre of ICL2 “outwards” from the receptor 
core, and docked RCP locally using the ROSIE webserver, followed by sidechain 
refinements using Rosetta. In situ, the CLR/RAMP1 complex would be embedded in a 
lipid bilayer, therefore binding poses which were not compatible with this (i.e. with 
significant hydrophilic/charged portions of RCP extending into the membrane core) 
were discarded as unphysical.  
 
3. Results 
 
3.1 Expression of RCP and other receptor components 
We initially investigated the distribution of RCP and potential partners in HEK293S, 
HEK293T and HUVEC cells (Figs 1a, b and c). All three cells expressed RCP and CLR; 
the HEK293S and T cells had additionally RAMPs 1 and 2 whereas HUVECs expressed 
only RAMP2. The specificity of the siRNA construct against RCP was shown in 
HUVECs, where it only reduced RCP expression (Fig 1c).  Furthermore, in HEK293S 
cells, cell surface ELISA confirmed that expression of HA-CLR in the presence of 
RAMP1 was unaffected by siRNA to RCP (135 ± 35% of control treated with 
scrambled siRNA, n =3). 
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Figure 1: Expression of receptor components and their selectively knocked down 
by siRNA. A) Expression of receptor components by RT-PCR in HEK293S cells; B) 
Expression of receptor components by RT-PCR in HEK293T cells; C) Expression of 
receptor components by RT-PCR in HUVEC cells with the effect of pretreatment with 
100 nM RCP siRNA to 100 nM scrambled siRNA for 48h.  Statistical testing was by 
Student’s t. Means, s.e.ms and individual data points are illustrated.  
 
3.2 RCP is an allosteric modulator of CLR that influences agonist bias 
Further investigations showed that CGRP stimulated cAMP production (Gs) (pEC50 
9.34 ± 0.27), pERK phosphorylation (pEC50 10.09 ± 0.40) and increased intracellular 
calcium mobilisation (Gαq) (pEC50 5.96 ± 0.30); in the presence of pertussis toxin 
there was no significant increase in CGRP potency on cAMP production (Fig 2), 
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suggesting that in these cells, there was little or no coupling to Gi. Whilst there were 
no differences in the responses in the presence of siRNA to knock down RCP for 
pERK, calcium, or pertussis toxin, for cAMP the Emax was reduced by 33.5 ± 2.9% 
(P<0.001, Student’s t) with no change in the pEC50 (Fig. 2).  
 
 
Figure 2: RCP specifically influences agonist bias at the CGRPR by selectively 
enhancing coupling to Gs. In transfected HEK293S cells CGRP-mediated cAMP 
production is impaired by RCP knockdown (A) but not Ca2+ mobilisation (B), pertussis 
toxin sensitivity (C) or activation of pERK (D). In all experiments n = 3 ± S.E.M. 
 
3.3 RCP interacts with a subset of family B GPCRs 
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Current pharmacological studies point to a direct interaction with intracellular loops 
2 (ICL2) of CLR [8]. For Family B GPCRs, there is a high degree of sequence 
conservation within this region, and could therefore indicate possible interactions of 
RCP with other family B receptors. We therefore investigated whether knock down 
of RCP affects signalling of other family B receptors. We observed impairment of the 
maximum cAMP production (but not pEC50) in transfected HEK293S cells by CT at the 
CTR (100.00 ± 4.95 to 72.47 ± 7.09, P = 0.0319), CRF at the CRF1a receptor (100.00 ± 
3.87 to 72.23 ± 3.39, P = 0.0319) and GLP-2 at the GLP-2R (100.00 ± 6.04 to 66.16 ± 
4.13, P = 0.029) (Fig. 3, Table 2). For the AM1 receptor, GIPR and GLP1R, there were 
no significant changes to Emax or pEC50.  
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Figure 3: RCP knockdown impairs cAMP production at other family B receptors. In 
transfected HEK293S cells, cAMP production was attenuated at the CTR (B), CRF1aR 
(D) and GLP2R (F) with their cognate ligands but not at the AM receptor (A), GIPR (C) 
and GLP1R (E). In all experiments, n = 3± S.E.M. 
 
 
Table 2 : Emax and pEC50 values for GPCR cAMP RCP knockdown assays 
GPCR Peptide Scrambled siRNA 
Emax 
siRNA RCP 
Emax 
Scrambled siRNA 
pEC50 
siRNA RCP 
pEC50 
CLR + RAMP1 CGRP 100.00 (± 4.33) 73.33 (± 2.88)*** 8.97 (± 0.13) 8.76 (± 0.13) 
CLR + RAMP2 AM 100.00 (± 4.95) 105.70 (± 4.69) 8.90 (± 0.15) 8.72 (± 0.14) 
CRF1aR CRF 100.00 (± 3.89) 72.47 (± 7.09)** 9.16 (± 0.12) 9.03 (± 0.14) 
CTR CT 100.00 (± 6.04) 72.47 (± 7.09)* 9.09 (± 0.25) 8.87 (± 0.26) 
GIPR GIP 1-42 99.99 (± 17.43) 108.60 (± 13.53) 9.07 (± 0.55) 9.32 (± 0.42) 
GLP1R GLP1 7-36 100.00 (± 8.66) 98.53 (± 8.32) 10.43 (± 0.33) 10.41 (± 0.33) 
GLP2R GLP2 1-33 100.00 (± 6.04) 66.16 (± 4.13)* 9.043 (± 0.17) 8.93 (± 0.19) 
 
All values are n>3, ± S.E.M. *, **, ****, P<0.05, 0.01, 0.001, Student’s t. Values are 
normalised to cAMP seen with 10M forskolin. 
 
3.4. RCP action on endogenously expressed CGRP and AM1 receptors 
We next investigated whether RCP knock down affected the signalling of 
endogenously expressed family B receptors in SK-N-MC [16], HEK293T [12] and 
HUVEC [17] cells. RCP knockdown by siRNA reduces agonist stimulated cAMP 
production by endogenously expressed CGRPR in SK-N-MC cells (Fig. 4a). There was 
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no significant change to Emax (albeit this may not be robustly defined as it is relies 
only on data from one point) but there was a significant change to pEC50 upon RCP 
knockdown (pEC50 9.16 ± 0.12 to 8.37 ± 0.13, P < 0.0001). We observed marginal 
effects upon the CTR expressed by HEK293T cells (Fig. 4b), and no effects upon the 
AM1 receptor in HUVECs (Fig. 4c), although both these cell lines express RCP (Figs 1b, 
c). 
 
Figure 4. Effects of RCP knockdown on Gs coupling of endogenous receptors. cAMP 
levels were determined from A; SK-N-MC B; HEK293T and C; HUVECS when 
stimulated with agonists (CGRP in A), CT in B) and AM in C) in the presence or 
absence of siRNA to RCP. For each data set, n = at least 3 ± S.E.M.   
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3.5 Molecular modelling of RCP and its interactions with CLR/RAMP1 
As there is evidence that RCP interacts with TM3/ICL2 of CLR [8], we carried out 
docking simulations of RCP (modelled using the yeast homologue C17, PDB ID: 3AYH) 
to the transmembrane domain of CLR, with both the N-terminus of CGRP and the 
trimeric Gαsβγ bound (from the cryo-electron microscope structure of this complex, 
PDB ID: 6E3Y). The best fit of RCP was to a surface formed by ICL2 of CLR and Gαs 
(Fig 5). This included the TM3/ICL2 peptide of CLR previously identified as the RCP 
contact site [8]. The Gαs interface with RCP involves the B-C loop that shows little 
homology to other G proteins. Within RCP, Lys24, Lys28 and Lys32 formed a strongly 
basic patch making electrostatic interactions with CLR and Gs and Lys32 would be 
able to interact with Trp254 of CLR. This Trp is also found in the calcitonin, CRF and 
the Drosophila CG174154 receptors, although in the GLP-2R it is an arginine. The 
CLR interface also overlaps with the interaction site between the C-terminus of 
RAMP1 and CLR [18]. In order to accommodate RCP, it is likely that there would have 
to be significant distortion of the C-terminus of the RAMP. Unfortunately, the 
residues at the extreme C-terminus of the RAMP are not resolved in the available 
structure (ie PDB ID: 6E3Y, making it hard to plausibly model. However, a role for the 
C-terminus of the RAMP would provide an explanation for why, in our hands, the 
CGRP (CLR/RAMP1) but not AM (CLR/RAMP2) receptors show a robust interaction 
with RCP.   
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Figure 5. Molecular model of the RCP in complex with RAMP1-CLR. A; Model of RCP 
(light blue), CLR (yellow), CGRP (purple), Gαs (dark blue) Gβ (green), Gγ (red). B; 
Interface between ICL2 of CLR (yellow), RCP (light blue) and Gαs (dark blue), marking 
Lys34 and Trp254.  
 
4. Discussion 
In this paper we have demonstrated that RCP acts on the CGRP receptor to 
selectively augment coupling to Gs/cAMP but not Gq/Ca2+ or pERK activation. The 
lack of significant Gi coupling observed in control cells makes it hard to say whether 
this is influenced by RCP but we saw no signs of any augmentation after RCP knock-
down. We have previously noted a lack of Gi coupling at the CGRP receptor in 
HEK293 cells [15]. RCP can also promote cAMP accumulation in transfected HEK293S 
cells at the CT, CRF and GLP2 receptors but not for the AM1, GIPR and GLP1 
receptors. It is clear the RCP is of more general significance for family B GPCRs than 
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previously thought, potentially acting as an allosteric modulator to promote Gs 
coupling. Interestingly, a Drosophila family B GPCR, CG17415, also appears to 
interact with a homologue of RCP and human RCP can enhance coupling of this 
receptor to Gs. Thus RCP-receptor interactions may have co-evolved with the 
emergence of family B GPCRs [19].  The physiological implications of an increased 
role for RCP remain to be documented.  
 
We found variations in the response to RCP as its knock-down in HEK293T cells 
expressing an endogenous calcitonin receptor (as seen in Fig 4b) had little effect on 
cAMP, unlike transfected cells. Further, whilst we observed no effect of RCP 
knockdown on the responsiveness of the AM1 receptor in transfected cells or 
HUVECs endogenously expressing the receptor, in NIH3T3 cells, the activation of an 
endogenous AM1 receptor was impaired when these were modified to express an 
antisense RNA directed against RCP [5]. The dependence of RCP on cell line recalls 
similar variability seen with RAMPs [12, 20]. In both cases, this is likely to be due to 
differences in signalling components between cell lines. Differences in receptor 
expression (by changing receptor reserve) will particularly influence the sensitivity of 
the maximum response to modulators. With a large receptor reserve, a decrease in 
receptor function will appear as a change in EC50 whereas if there is no reserve, then 
an effect on maximum response would be apparent. However, in the current study, 
we see a decrease in maximum response in transfected cells where receptor it might 
be expected that there is a large receptor reserve assuming efficient transfection. 
Other factors such as scaffolding proteins and access to G proteins might be 
important, as well as translational regulation of receptor components, only 
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functional in cells endogenously expressing the relevant receptor. Furthermore, 
reversible covalent modifications such as phosphorylation could potentially play a 
role in governing RCP-receptor interactions. Thus these may be subject to dynamic 
control, an interesting concept given evidence that RCP is also translocated to the 
nucleus after CLR activation [9]. 
 
To fully appreciate the physiological significance of these results, it will first be 
important to examine the co-distribution of receptors and RCP at a cellular level in 
tissues, or at least in primary cells derived from tissues. Lack of this information has 
greatly hindered the physiological understanding of RAMPs [21]. However, RCP has 
the potential to accentuate cAMP signalling over other pathways and this will be 
particularly significant where the latter are associated with deleterious effects [22]                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     
 
In conclusion, we have demonstrated that RCP can act as a positive allosteric 
modulator, promoting the coupling of specific family B receptors to Gs. Future work 
could usefully be directed at understanding the significance of this. 
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Highlights 
 RCP promotes coupling of the CGRP receptor to Gs but not Gi or ERK 
activation 
 RCP enhances Gs coupling for the calcitonin, CRF 1a and  GLP-2 receptors 
 RCP does not act on adrenomedullin 1, GIP or GLP-1 receptors in HEK293S 
cells 
 The actions of RCP depend on the cell line background. 
Journal Pre-proof
